GT Biopharma, Inc.GTBPNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank36
3Y CAGR-47.3%
5Y CAGR-25.6%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-47.3%/yr
vs +14.5%/yr prior
5Y CAGR
-25.6%/yr
Recent deceleration
Acceleration
-61.8pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 9.94% |
| 2024 | -23.05% |
| 2023 | -754.55% |
| 2022 | 67.96% |
| 2021 | 68.06% |
| 2020 | 43.52% |
| 2019 | 86.98% |
| 2018 | 39.61% |
| 2017 | -100.24% |
| 2016 | 104.28% |